1 study on Lars1 mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research positions MOTS-c as a novel and highly promising therapeutic candidate for ovarian cancer, offering a new avenue for treatment. By specifically targeting the USP7-LARS1 pathway, MOTS-c introduces a disti…